entertainment
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Winners, losers from Medicare’s list of drugs subject to price talks
Next article: Winners, losers from Medicare’s list of drugs subject to price talks
hotspot
focus
-
Radiation, mainstay of cancer treatment, begins a fade
2025-10-01 21:33 -
Neuroscience startup Neumora files for IPO
2025-10-01 21:22 -
AstraZeneca bets AAV gene therapy will still deliver the goods
2025-10-01 20:20 -
Apellis safety probe of eye disease drug centers on injection needle
2025-10-01 20:03 -
Medicare drug price negotiation hearing pits pharma v Biden admin
2025-10-01 19:56 -
Neuroscience startup Neumora files for IPO
2025-10-01 19:17